|
1 |
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
|
National Leader: Dr Denis Xavier |
Year of initiation: July 2024 |
|
2 |
Prevalence, Risk factors, COnsequences and opporTunities for prevention of falls in Elderly with select Chronic condiTions (PROTECT 2): A Mixed Methods Study
|
PI- Dr. Denis Xavier, Co-I: Dr. Atiya Faruqui, Dr. Arvind Kasturi, Dr. Jonita Furtado, Dr. Pretesh R |
Year of initiation: 2025 |
|
3 |
Zilebesiran Cardiovascular Outcomes Trial (ZCVOT)
|
National Leaders and SC : Dr Denis Xavier |
Year of initiation: 2025 |
|
4 |
Presentation, tReatments, challenges and Opportunities for optimal Treatments in the Elderly with select Chronic condiTions (PROTECT) Study
|
PI: Dr. Atiya R. Faruqui, Co-I: Dr. Arvind Kasthuri, Dr. Denis Xavier, Dr. Jonita, Dr. Pretesh Kiran |
Year of initiation: 2024 |
|
5 |
Development and validation of a deprescribing tool relevant to the Indian context and evaluation of its effectiveness in reducing inappropriate polypharmacy in the elderly (ICMR-SRUM-NTF)
|
PI: Dr. Atiya R. Faruqui, Co-I: Dr. Geetha Francis, Dr. Pretesh Kiran |
Year of initiation: 2023 |
|
6 |
Pregnancy outcomes and it’s determinants at a tribal hospital in south India– A prospective cohort study (PREDICT)
|
PI- Dr. Denis Xavier, Co-I : Dr. Padmini Devi , Dr Deepa. S, Dr. Ryan Fernandez |
Year of initiation: 2022 |
|
7 |
A Phase 3, Randomized, Double-Blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of an Oral Factor XIa Inhibitor, after a Recent Acute Coronary Syndrome (Milvexian ACS)
|
National Leader- Dr Denis Xavier |
Year of initiation: 30th Oct 2023 |
|
8 |
COLchicine and Thiamine in Heart Failure due to Ischemic Heart Disease (COLT-HF)
|
PI- Dr Denis Xavier, Co-I- Dr Mangala Rao |
Year of Initiation : 2024 |
|
9 |
Impact, cost-effectiveness, and sustainability of a synergistic, multipronged, customized, low-cost intervention package (IP) to reduce cardiovascular disease (CVD) burden among diverse populations across India (ICMR-CAR)
|
PI : Dr Denis Xavier |
Year of Initiation : 2024 |
|
10 |
Prospective Global Platform to Evaluate and Enhance Cognitive and Functional Trajectories after Stroke (PROSPECT)
|
PI- Dr. Denis Xavier Co-I- Dr. Atiya R Faruqui |
Year of Initiation : 2024 |
|
11 |
RADICAL PC1- Role of Androgen Deprivation Therapy In CArdiovascular Disease – A Longitudinal Prostate Cancer Study. RADICAL PC2- A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients.
|
PI: Dr Denis Xavier, Co I: Dr Deepa S |
Year of Initiation : 2023 |
|
12 |
ENRICH-AF - EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation
|
PI: Dr. Denis Xavier, Co-I: Dr. Padmini Devi |
Year of Initiation : 2020 |
|
13 |
ACHIEVE -Aldosterone bloCkade for Health Improvement EValuation in End-stage renal disease
|
PI: Dr. Denis Xavier, Co-I: Dr.Atiya Faruqui |
2019 |
|
14 |
POISE-3 - Peri-Operative ISchemic Evaluation-3
|
PI: Dr Denis Xavier |
2018 onwards |